Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.59 USD | +0.66% |
|
-6.13% | -32.20% |
06-03 | UniQure Shares Rise After US FDA Grants Regenerative Medicine Advanced Designation for Huntington's Treatment | MT |
06-03 | UniQure's AMT-130 Gets FDA RMAT Designation in Huntington's Disease | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.20% | 223M | |
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B |
- Stock Market
- Equities
- QURE Stock
- News uniQure N.V.
- Transcript : UniQure N.V. - Special Call